Source: Eur Respir J 2015; 46: 1701-1710
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hellenkamp Kristian, Schwung Johanna, Rossmann Heidi, Kaeberich Anja, Wachter Rolf, Hasenfuß Gerd, Konstantinides Stavros, Lankeit Mareike. Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin. Eur Respir J 2015; 46: 1701-1710

Member's Comments

No comment yet.

Related content which might interest you: Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Prognostic role of cardiac troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Shock index as a prognostic value in risk stratification of patients with acute pulmonary embolism Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Validation of a prognostic score for pulmonary embolism short-term mortality Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension Year: 2015 Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both? Source: Eur Respir J 2015; 46: 1551-1553 Year: 2015 Refining risk in normotensive acute pulmonary embolism Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Determinants and prognostic impact of diagnostic delay in pulmonary embolism Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment Year: 2018 High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism Source: ERJ Open Res, 6 (4) 00625-2020; 10.1183/23120541.00625-2020 Year: 2020 Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study Source: Eur Respir J, 51 (4) 1702037; 10.1183/13993003.02037-2017 Year: 2018 Combination of prognostic tools for identifying high-risk normotensive patients with acute symptomatic pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism Source: Eur Respir J 2008; 31: 847-853 Year: 2008 Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015 Towards prognostic biomarkers in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 799-801 Year: 2012 Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004 Prognostic value of the ECG on admission in patients with acute major pulmonary embolism Source: Eur Respir J 2005; 25: 843-848 Year: 2005 The signifigance of NT-proBNP value pulmonary tromboembolism in early mortality Source: Annual Congress 2006 - Pulmonary embolism Year: 2006 Prognostic value of troponin I in patients with non-massive acute pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Prognostic impact of exercise pulmonary hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Predictors and prognostic factors in a large Pulmonary embolism series Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021